Our
Teams
2025 Startups
ADA
At ADA, we are revolutionizing menstrual care for the visually impaired. Our innovative, discreet sensor seamlessly integrates with period pads, providing timely, vibration-based alerts when it's time for a change. We empower individuals with visual impairments to manage their menstrual cycles with confidence, dignity, and independence. ADA is committed to inclusive design, ensuring that everyone has access to intuitive, hygienic menstrual care solutions.
Contact ADA
Clearsite.ai
Enterprise software teams are under growing pressure to ship accessible, high-performing digital experiences, but they are stuck with aging codebases, fragmented development workflows, and inaccessible legacy UI components. Developers and designers often lack the tools, time, or training to properly address accessibility issues within fast-paced CI/CD cycles. As a result, accessibility responsibilities fall on a few overburdened specialists or are outsourced entirely, creating bottlenecks and compliance risk (TD Bank UX Lead, clearSite.ai deck). Meanwhile, AI overlay tools promise quick fixes but fail to resolve deeper usability barriers like keyboard navigation or screen reader flow (Sonya Allin, Accessibility Compliance Expert, clearSite.ai deck).
Enterprises face growing financial, legal, and reputational risks for inaccessibility. Over 3,000 ADA-related digital accessibility lawsuits were filed in the U.S. in 2024, continuing an upward trend (EcomBack 2024 ADA Lawsuit Report, PR Newswire). Globally, more than 1 billion people live with a disability (World Health Organization), and inaccessible digital journeys lead to cart abandonment, churn, and lost revenue. In North America and Europe alone, people with disabilities control over $2.6 trillion in disposable income (Return on Disability Group). Yet even as accessibility becomes a board-level concern, companies still lack scalable ways to catch issues before they ship.
Today’s accessibility solutions sit at two extremes: slow, expensive manual audits or one-click overlays that offer false security. Free tools like Lighthouse or axe-core surface only a fraction of WCAG violations, missing flow-breaking issues like tab traps and semantic errors (GitNation, “A11y Testing is Broken”). For mid to large enterprises migrating legacy stacks, these tools do not integrate deeply into development pipelines or help ship clean code at scale. There is a growing need for AI-native solutions that fit into modern CI workflows, flag issues early, and support developers in making accessibility part of every release without waiting for quarterly audits or legal triggers.
Contact Clearsite.ai
Halcyon
Hormonal imbalances affect 80% of women at some point in their lives, causing a myriad of
mental and physical symptoms that significantly reduce their quality of life. Studies indicate that
improving gut health can alleviate up to 60% of the issues associated with hormonal
imbalances. Despite this, current solutions are often generic and fail to address the unique
needs of individual women. Women deserve better—personalized health solutions tailored to
their unique microbiomes.
GutHarmony aims to fill this critical gap by offering bespoke, scientifically-backed solutions that
enhance women’s health and well-being through targeted gut microbiome analysis and
personalized health plans.
Contact Halcyon
Her2Her
Breast cancer has been a prominent topic of of women's health, and has contributed to over 2.3 million diagnoses and half a million deaths globally in 2022 alone, according to the WHO. Though breast cancer has been strongly associated with genetics through BRAC1/2 genes, there are a lot of other factors contributing to the disease. Biomarkers such as miRNAs and proteins have been strongly linked to breast cancer, with miRNAs playing key roles in early detection. Though breast cancer detection techniques have already been established, they are not as easily accessible, especially for women residing in low-income regions or in countries where access to healthcare is limited. Additionally, there is a lot of fear associated with breast cancer testing, resulting in low adherence to testing and late stage detection of the disease in some cases. This calls for the development of non-invasive and accessible early detection or screening methods for breast cancer.
Biomarkers for breast cancer can play a crucial role in early detection, especially miRNAs which show stable presence in saliva. Our aim is to draw upon the efficacy and accessibility of at-home tests to develop a latency flow test, similar to a PCR covid testing, to biomarkers associated with breast cancer within the saliva. This is a novel, non-invasive technique that presents a strong competitive edge as we aim to develop the device with the ability to simultaneously detect different types of biomarkers at once.
Contact Her2Her
Hygia Robotics
In Canada, approximately 2.7 million individuals aged 15 and older, representing 9.6% of the population, live with mobility disabilities, many of which involve upper limb impairments. This significant segment faces daily challenges in performing essential tasks, with eating being one of the most personal and impactful. The inability to eat independently diminishes personal dignity and places a substantial burden on caregivers, nearly two-thirds of whom are employed part-time and provide an average of 4.5 hours of care daily, a commitment that can feel like another full-time job. Current assistive feeding devices are often limited in functionality, lack customization, and fail to adapt to diverse user needs, creating a critical gap in the market that leads to caregiver burnout, financial strain, and a decline in the overall quality of care.
Contact Hygia Robotics
MystiPhage
Antibiotic resistance (ABR) is a global threat that is projected to cause over 10 million deaths per year and $100 trillion in economic losses by 2050 (UN, WHO). As this threat grows, we are running out of time to come up with a solution that puts humankind ahead. Phage therapy, which uses tiny viruses called phages to kill bacteria, represents an extremely promising pathway to help combat ABR. The key to phage therapy is in the specific way it interacts with the superbug bacteria infecting a patient. The specific way the bacteria are infected and killed can possibly be very harmful to the patient themselves; the difficulty in making therapeutic phages that don’t have these adverse effects is currently the limiting factor in phage therapy that is preventing it from saving millions of lives. To solve this, we are developing a platform that leverages generative AI to custom-make phages with the optimal infection characteristics for a given bacteria and patient. This way, we can make suitable phages for phage therapy that have no adverse effects and target bacteria with higher efficiency, which will save millions of lives. The total addressable market of antibiotic resistance worldwide is $12.50 billion USD, the serviceable addressable market in healthcare is $9.12 billion USD, and the serviceable obtainable market sits at $1.1 billion USD. All numbers are based on 2030 projections.
Contact MystiPhage
NanoFlux
The global ion exchange membrane (IEM) market, valued at over $12 billion, is critical for CO2 electrolyzers, water treatment, energy storage, and hydrogen production. However, current IEMs are expensive, inefficient, and reliant on PFAS-based materials, which are environmentally harmful and increasingly regulated. These limitations increase costs, hinder scalability, and slow industrial decarbonization, affecting industries that rely on membrane-based processes for carbon capture and clean energy production. Despite advancements in membrane science, existing technologies remain inadequate for scalable carbon capture, CO2 electrolysis, and hydrogen production, limiting their climate impact.
For example, CO2 electrolyzers, which convert carbon dioxide into valuable liquid fuels and chemicals such as ethanol and formic acid, suffer from low efficiency and poor liquid product concentration due to membrane limitations, significantly reducing their economic viability. These inefficiencies stem from poor ion selectivity, high resistance, and high energy consumption, making large-scale deployment costly. Meanwhile, rising CO2 emissions accelerate ocean acidification, weakening the ocean’s ability to sequester carbon and worsening climate instability. Enhancing membrane efficiency is essential for improving CO2 conversion and ocean acidification mitigation, yet existing membranes fail to meet cost, energy, and performance demands, preventing widespread adoption.
Contact NanoFlux
Osteo360
Falls are a frequent and costly issue in Canadian long-term care (LTC) homes, with nearly 50% of residents experiencing at least one fall each year according to the Canadian Geriatrics Journal (2020). These incidents come at a steep price— According to McKnight’s Senior Living (2023) each fall costs LTC homes approximately $7,000 CAD in direct care expenses, while resulting lawsuits can range from $100,000 to $1 million. According to Geriatric Nursing (2022), 30% of these falls result in residents remaining on the ground for over an hour, significantly increasing the risk of complications and harm. The urgency of addressing this problem is underscored by both the financial burden and the potential for severe health outcomes. Current solutions—such as hip protectors and staff monitoring—have proven insufficient. Statistics Canada reports vacancies for registered nurses and psychiatric nurses in Canada reached 28,335 in early 2023 — a 24% jump in just one year, the largest increase of any occupation in the country. Hip protectors from companies like HipSaver, SafeHip, Helite, and Geri Hips suffer from low adoption rates, often due to discomfort or poor fit. Meanwhile, overburdened nursing staff are unable to consistently monitor residents, leaving critical response gaps. A more effective, scalable, and user-friendly solution is urgently needed to address the shortcomings of existing interventions and improve fall response times in long-term care settings. The cost of inaction is at least 437,500 annually for long term care homes (cost of falls * frequency * number of residents)
Contact Osteo360
Scriptose
In today’s AI-driven tech landscape, traditional hiring methods—like puzzle-based coding tests—fail to identify engineers who genuinely excel at leveraging AI tools. Companies desperately need developers who combine coding expertise, AI-tool proficiency, and strong communication skills, yet existing assessments offer no visibility into these critical capabilities. This mismatch stalls productivity, delays projects, and leaves tech leaders struggling to recruit the very talent that could multiply their team’s output exponentially.
Contact Scriptose
